Breast cancer incidence in Canada
Description: Breast cancer incidence in Canada
Breast cancer is the most common cancer in Canadian women, with 1 in 8 women expected to be diagnosed with breast cancer in their lifetime and 1 in 36 expected to die from the disease.Note 1
Understanding how female breast cancer rates change over time helps cancer awareness efforts and contributes to improving diagnosis and treatment.
From 1984 to 2019, breast cancer rates increased in women under 50.Note 2
| Diagnosis year | Age group | ||
|---|---|---|---|
| 20 to 29 years | 30 to 39 years | 40 to 49 years | |
| 1984 | 3.94 | 36.83 | 126.55 |
| 1985 | 4.15 | 38.52 | 128.76 |
| 1986 | 3.51 | 35.87 | 124.51 |
| 1987 | 4.05 | 38.73 | 123.92 |
| 1988 | 3.81 | 38.53 | 134.77 |
| 1989 | 3.70 | 36.47 | 126.89 |
| 1990 | 4.35 | 34.11 | 134.66 |
| 1991 | 3.72 | 35.49 | 129.01 |
| 1992 | 3.02 | 35.07 | 139.09 |
| 1993 | 3.66 | 36.35 | 132.91 |
| 1994 | 3.94 | 35.60 | 135.61 |
| 1995 | 4.16 | 36.90 | 130.97 |
| 1996 | 3.22 | 36.81 | 132.84 |
| 1997 | 3.34 | 36.34 | 138.26 |
| 1998 | 3.21 | 39.17 | 131.85 |
| 1999 | 4.29 | 40.97 | 135.51 |
| 2000 | 3.39 | 35.90 | 130.33 |
| 2001 | 3.61 | 38.13 | 131.03 |
| 2002 | 3.37 | 39.64 | 130.69 |
| 2003 | 3.09 | 37.90 | 126.45 |
| 2004 | 2.95 | 37.20 | 133.49 |
| 2005 | 5.01 | 37.53 | 141.09 |
| 2006 | 4.12 | 38.40 | 137.30 |
| 2007 | 3.66 | 39.11 | 132.70 |
| 2008 | 5.40 | 36.92 | 135.96 |
| 2009 | 4.66 | 36.67 | 139.10 |
| 2010 | 5.22 | 40.31 | 141.96 |
| 2011 | 5.22 | 39.74 | 142.55 |
| 2012 | 4.59 | 40.66 | 138.27 |
| 2013 | 4.96 | 36.92 | 135.38 |
| 2014 | 5.43 | 40.47 | 139.01 |
| 2015 | 5.38 | 42.36 | 136.45 |
| 2016 | 5.50 | 40.23 | 139.33 |
| 2017 | 5.81 | 42.91 | 139.16 |
| 2018 | 5.55 | 44.12 | 141.37 |
| 2019 | 6.07 | 42.47 | 140.76 |
Breast cancer has multiple subtypes, some being more aggressive than others. Triple negative is one of the more aggressive subtypes.
| Time since diagnosis (years) | Luminal A | Luminal B | Luminal B-like | HER2-enriched | Triple negative | Unknown |
|---|---|---|---|---|---|---|
| net survival (%) | ||||||
| 0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| 0.5 | 100.0 | 99.1 | 98.7 | 97.7 | 97.2 | 91.3 |
| 1 | 100.0 | 98.1 | 98.0 | 95.5 | 94.0 | 88.4 |
| 1.5 | 100.1 | 96.6 | 97.0 | 93.4 | 89.5 | 86.0 |
| 2 | 100.0 | 95.1 | 96.0 | 91.4 | 85.9 | 83.6 |
| 2.5 | 99.7 | 93.6 | 94.5 | 88.9 | 82.8 | 81.1 |
| 3 | 99.5 | 91.6 | 93.0 | 86.3 | 80.6 | 79.0 |
| 3.5 | 99.1 | 90.0 | 91.6 | 84.9 | 78.3 | 77.2 |
| 4 | 98.9 | 88.7 | 90.8 | 83.9 | 76.8 | 75.6 |
| 4.5 | 98.5 | 87.3 | 90.3 | 82.9 | 75.6 | 73.8 |
| 5 | 98.4 | 86.0 | 88.8 | 82.0 | 74.5 | 71.7 |
Triple negative breast cancer accounts for approximately…
- 1 in 10 cases overallNote 3
- 1 in 5 cases among women diagnosed under the age of 40Note 3
- 1 in 5 cases among Black womenNote 4
Sources: Canadian Cancer Society, 2023, Canadian Cancer Statistics; Seely, J. M., L. F. Ellison, J. M. Billette, S. X. Zhang and A. N. Wilkinson, 2024, “Incidence of Breast Cancer in Younger Women: A Canadian Trend Analysis,” Canadian Association of Radiologists Journal, 75(4), 847–854; Wilkinson, A. N., L. F. Ellison, S. F. McGee, J. M. Billette and J. M. Seely, 2024, “The Landscape of Breast Cancer Molecular and Histologic Subtypes in Canada,” Current Oncology, 31(9), 5544–5556; Wilkinson, A. N., C. Ng, L. F. Ellison and J. M. Seely, 2025, “Breast cancer incidence and mortality, by age, stage and molecular subtypes, by race/ethnicity in Canada,” The Oncologist, 30(8).
- Date modified: